期刊文献+

Toll样受体与2型糖尿病及其并发症的关系及分子机制 被引量:2

Relationships and Molecular Mechanisms of Toll-like Receptors and Type 2 Diabetes and Its Complications
下载PDF
导出
摘要 Toll样受体(TLR)是固有免疫系统的一类重要受体,通过识别病原体相关的分子模式诱导机体产生炎性反应,而炎症是2型糖尿病及其并发症的重要病理生理过程。TLR参与2型糖尿病患者的胰岛素抵抗、β细胞功能障碍及并发症的发生和发展,其机制可能包括2型糖尿病患者体内存在的糖脂代谢紊乱持续激活TLR,诱导活性氧和细胞因子产生增加,并最终导致炎性反应。对TLR认识的进一步深入,将为2型糖尿病的抗炎性治疗和免疫干预提供新的思路。 Toll-like receptors(TLR) are an important class of receptors of the innate immune system. Its activation can induce inflammatory response by recognizing pathogen associated molecular patterns while inflammation is an important pathophysiological process of type 2 diabetes and its complications. Studies have shown that TLR is involved in the development of insulin resistance and ~ c.ell d~,'sfunction of type 2 diabetic patients and its complications. The mechanism may include the glucose and lipid disorders involved in type 2 diabetes sustained activation of TLR,induction of reactive oxygen species and cytokine production increase, which eventually lead to the inflammatory response. The further understanding of TLRs would provide new methods of anti-inflammation therapy and immune intervention for type 2 diabetes mellitus.
作者 吴冕 陈海冰
出处 《医学综述》 2013年第20期3754-3757,共4页 Medical Recapitulate
基金 2010年教育部新世纪优秀人才支持计划
关键词 TOLL样受体 2型糖尿病 炎症 Toll-like receptors Type 2 diabetes mellitus Inflammation
  • 相关文献

参考文献31

  • 1Medzhitov R,Preston-Hurlburt P,Janeway CA Jr. A human homo- logue of the Drosophila Toll protein signals activation of adaptive immunity [ J ]. Nature, 1997,388 ( 6440 ) : 394-397.
  • 2Akira S, Takeda K. Toll2 like receptor signaling [ J ]. Nat Rev lmmunol, 2004,4 ( 7 ) :499-511.
  • 3Dasu MR, Devaraj S, Park S, et al. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects [ J ]. Diabetes care,2010,33 ( 4 ) : 861-868.
  • 4Dasu MR, Park S, Devaraj S,et al. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice[J]. Endocrinology,2009,150 ( 8 ) :3457-3464.
  • 5Reyna SM, Ghosh S,Tantiwong P, et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects [J]. Diabetes, 2008,57 ( 10 ) : 2595 -2602.
  • 6Creely SJ, McTernan PG, Kusminski CM,et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes[J]Am J Physiol Endoerinul Metab ,2007,292( 3 ) : E740-E747.
  • 7Ehses JA, Meier DT, Wueest S, et al. Toll-like receptm" 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet[J]. Diabetologia,2010,53(8) :1795-1806.
  • 8Monden M, Koyama H, Otsuka Y, et al. Receptor for advanced gly- cation end products regulates adipocyte hypertrophy and insulin sensitivity in mice : involvement of Toll-like receptor 2 [J] Diabe- tes ,2012,62 (2) :478-489.
  • 9Hussey SE, Liang H, Costford SR, et al. TAK-242, a small molecule inhibitor of Toll-like receptor-4 signaling, unveils similarities and differences in lipopolysaceharide-and lipid-induced inflammation and insulin resistance in muscle calls [ J ]. Biosei Rep, 2012,33 ( 1 ) :37-47.
  • 10Kim HS, Han MS, Chung KW, et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune dia- betes [J]. Immunity,2007,27 ( 2 ) : 321-333.

同被引文献62

引证文献2

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部